Related Experiment Videos

[Efficacy and tolerance of vaccinations in premature infants]

P Saliou1, N Ajjan, N Guérin

  • 1Aventis Pasteur, 2, avenue Pont-Pasteur, 69367 Lyon, France. pierre.saliou.aventis.com

Insights

Timely immunization is crucial for preventing infectious diseases in preterm infants. Key vaccines, like DTaP-IPV-Hib, should start at 2 months, with special monitoring for apnea in hospitalized infants.

Area of Science:

  • Pediatrics
  • Immunology
  • Neonatology

Context:

  • Preterm infants face unique challenges regarding immunization schedules and vaccine responses.
  • Immune system maturation is primarily age-dependent, not solely based on gestational age.

Purpose:

  • To review the effectiveness, safety, and duration of protection for immunizations in preterm infants.
  • To provide evidence-based recommendations for optimizing vaccination strategies in this vulnerable population.

Summary:

  • Immunization schedules should align with chronological age, initiating vaccines like diphtheria-tetanus-pertussis-poliomyelitis-Haemophilus influenzae b at 2 months.
  • Preterm infants may require monitoring for apnea post-vaccination, particularly with the pertussis component.
  • BCG vaccination is not recommended immediately after birth for infants under 33 weeks gestation, and Hepatitis B vaccination can be given at 2 months or at birth for high-risk newborns.

Impact:

  • Ensures appropriate and timely protection against serious infectious diseases for preterm infants.
  • Highlights the need for careful monitoring and tailored vaccination approaches in neonatal care.
  • Confirms that prematurity does not alter the safety or duration of immunity for most standard vaccines.

Related Concept Videos